Literature DB >> 8336944

Efficient screening of p53 mutations by denaturing gradient gel electrophoresis in colorectal tumors.

R Hamelin1, N Jego, P Laurent-Puig, M Vidaud, G Thomas.   

Abstract

Alterations in exons 5-8 of the p53 gene have been found in the vast majority of human tumors. Although some specific codons have been revealed as preferential mutational sites in defined tumor types, mutations are generally so scattered within this region that various screening methods for their detection have been widely used. However, the capacity of these techniques to detect exhaustively all mutations has not been evaluated. In this report, conditions for analysing exons 5-8 of the p53 gene by denaturing gradient gel electrophoresis (DGGE) have been elaborated using the Melt87 and SQHTX computer programs. The procedure requires five different amplifications. The screening of 90 colorectal tumors revealed 56 amplification products demonstrating abnormal DGGE behavior. Direct sequencing of these amplification products after asymmetric polymerase chain reaction (PCR) showed, besides polymorphism, 49 somatically mutated DNA samples (54.4%) corresponding to 38 different p53 variants. Moreover, 25 additional p53 variants identified in other tumor types were also detectable with our conditions. Thus, altogether the procedure has been successfully used in the detection of 63 different p53 variants. The experimental differences in migration between the wild-type homoduplex DNA molecule and the heteroduplex(es) containing one mismatch were systematically compared with those calculated by the SQHTX program. The computer program was found to be reliably predictive. This DGGE procedure appears thus to be effective and reliable for detecting mutations in exons 5-8 of the p53 gene.

Entities:  

Mesh:

Year:  1993        PMID: 8336944

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  14 in total

1.  Analysis of the p21 gene in gliomas.

Authors:  Y J Li; K Hoang-Xuan; X P Zhou; M Sanson; K Mokhtari; T Faillot; P Cornu; M Poisson; G Thomas; R Hamelin
Journal:  J Neurooncol       Date:  1998-11       Impact factor: 4.130

2.  p53 gene mutations in soft-tissue sarcomas--correlations with p53 immunohistochemistry and DNA ploidy.

Authors:  R Schneider-Stock; K Radig; Y Oda; W Mellin; J Rys; A Niezabitowski; A Roessner
Journal:  J Cancer Res Clin Oncol       Date:  1997       Impact factor: 4.553

3.  Apoptosis in rheumatoid arthritis: p53 overexpression in rheumatoid arthritis synovium.

Authors:  G S Firestein; K Nguyen; K R Aupperle; M Yeo; D L Boyle; N J Zvaifler
Journal:  Am J Pathol       Date:  1996-12       Impact factor: 4.307

4.  p53 abnormalities in adenocarcinoma of the gastric cardia and antrum.

Authors:  J F Fléjou; V Gratio; F Muzeau; R Hamelin
Journal:  Mol Pathol       Date:  1999-10

5.  BRCA1 sequence variations in 160 individuals referred to a breast/ovarian family cancer clinic. Institut Curie Breast Cancer Group.

Authors:  D Stoppa-Lyonnet; P Laurent-Puig; L Essioux; S Pagès; G Ithier; L Ligot; A Fourquet; R J Salmon; K B Clough; P Pouillart; C Bonaïti-Pellié; G Thomas
Journal:  Am J Hum Genet       Date:  1997-05       Impact factor: 11.025

6.  Molecular and clinical differences between adenocarcinomas of the esophagus and of the gastric cardia.

Authors:  P Tanière; G Martel-Planche; D Maurici; C Lombard-Bohas; J Y Scoazec; R Montesano; F Berger; P Hainaut
Journal:  Am J Pathol       Date:  2001-01       Impact factor: 4.307

7.  Single base pair germ-line deletion in the p53 gene in a cancer predisposed family.

Authors:  R Hamelin; F Barichard; I Henry; C Junien; G Thomas
Journal:  Hum Genet       Date:  1994-07       Impact factor: 4.132

8.  Antibodies against p53 protein in serum of patients with benign or malignant pancreatic and biliary diseases.

Authors:  P Laurent-Puig; R Lubin; S Semhoun-Ducloux; G Pelletier; C Fourre; M Ducreux; M J Briantais; C Buffet; T Soussi
Journal:  Gut       Date:  1995-03       Impact factor: 23.059

9.  Molecular-genetic characterisation of gliomas that recur as same grade or higher grade tumours.

Authors:  T J M Hulsebos; D Troost; S Leenstra
Journal:  J Neurol Neurosurg Psychiatry       Date:  2004-05       Impact factor: 10.154

10.  Detection of p53 gene mutations by nonisotopic RNase cleavage assay as a predictor of poor prognosis in colorectal cancers.

Authors:  Masatoshi Haseba; Shigekazu Hidaka; Takashi Tsuji; Hiroshi Yano; Hideaki Komatsu; Terumitu Sawai; Toru Yasutake; Tohru Nakagoe; Yutaka Tagawa; Hiroyoshi Ayabe
Journal:  Dig Dis Sci       Date:  2003-10       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.